Market news

Press releaseAEPAmerican Electric Power Company, Inc.·Oct 28, 2026

American Electric Power Company, Inc. reported third-quarter 2026 GAAP earnings of $1,187 million, or $2.18 per share, compared to $972 million, or $1.82 per share, in the third quarter of 2025. Operating earnings for the quarter reached $1,216 million, or $2.23 per share. The company also announced an expanded $100 billion five-year capital plan through 2031 and raised its full-year 2026 operating earnings guidance.

Source: SEC EDGAR

Press releaseDANDana Incorporated·Oct 28, 2026

Source: PR NewswireIndustry TRNIndustry TRTIndustry MACIndustry MNGIndustry AUTIndustry MCTSubject ERN

Press releasePAGPenske Automotive Group, Inc.·Oct 28, 2026

Source: PR NewswireIndustry AUTIndustry TRNSubject ERN

Press releaseLHLabcorp Holdings Inc.·Oct 28, 2026

Labcorp Holdings Inc. reported third quarter 2026 revenue of $3.81 billion, compared to $3.56 billion in the third quarter of 2025. Diluted earnings per share were $3.22, up from $3.12, while adjusted EPS reached $4.78 versus $4.18. The company also updated its full-year 2026 guidance, raising its projected revenue growth and adjusted EPS range.

Source: SEC EDGAR

Press releaseAEPAmerican Electric Power·Oct 28, 2026

American Electric Power reported third-quarter 2026 GAAP earnings of $1,187 million, or $2.18 per share, compared with $972 million, or $1.82 per share, for the third quarter of 2025. Operating earnings for the third quarter of 2026 were $1,216 million, or $2.23 per share. The company announced a $100 billion capital plan and an updated operating earnings growth outlook on October 28, 2026.

Source: PR NewswireIndustry EUTIndustry OILIndustry UTISubject ERN

Press releaseADPAutomatic Data Processing Inc.·Oct 28, 2026

Automatic Data Processing Inc. issued its press release reporting financial results for the first quarter of fiscal 2027. Revenues increased 6% compared to the prior year's first quarter to $5.5 billion. Net earnings increased 11% to $1.1 billion, and diluted earnings per share increased 14% to $2.83. The company also raised its full-year guidance for revenue and adjusted diluted EPS growth.

Source: SEC EDGAR

Press releaseBDXBD (Becton, Dickinson and Company)·Oct 28, 2026

On Oct. 28, 2026, BD (Becton, Dickinson and Company) announced the U.S. commercial launch of the BD® Liverty™ TIPS Stent Graft. The new system aims to advance portal hypertension care by giving physicians flexibility in treatment. The product is supported by the six-month interim results from the 177 patient ARCH clinical study.

Source: PR NewswireIndustry HEAIndustry MTCIndustry MEQSubject PDT

Press releaseLHLabcorp Holdings Inc·Oct 28, 2026

Labcorp Holdings Inc. reported third quarter 2026 revenue of $3.81 billion, up 6.9% compared to the third quarter of 2025. Diluted EPS for the quarter ended September 30, 2026, was $3.22, and adjusted EPS was $4.78. The company raised its full-year 2026 revenue growth guidance range to between 5.9% and 6.7% and its adjusted EPS range to between $18.30 and $18.70.

Source: PR NewswireIndustry MEQIndustry MTCIndustry HEAIndustry PHASubject ERN

Press releasePSXPhillips 66·Oct 28, 2026

Phillips 66 reported third-quarter 2026 earnings of $5.6 billion, or $14.08 per share, compared with $3.8 billion, or $9.55 per share, in the second quarter of 2026. The company returned $2.8 billion to shareholders through dividends and share repurchases during the quarter. Additionally, Phillips 66 decreased total debt by $2.0 billion to $18.5 billion.

Source: SEC EDGAR

Form 4ACNAccenture plc·Oct 28, 2026

Chair and CEO, Director Julie Spellman Sweet bought 12,200 shares of Class A ordinary shares in two purchases on 2026-10-26, paying an average price of $245.99 for a total value of $3,001,041.24. Following these transactions, the insider directly held 48,910 shares.

Source: SEC EDGAR

Form 4ACNAccenture plc·Oct 28, 2026

Director Paula A Price bought 800 shares of Accenture plc at an average price of $249.81 for a total value of $199,847.76 on October 26, 2026. Following this purchase, the insider directly held 9,361 Class A ordinary shares.

Source: SEC EDGAR

Press releaseLLYEli Lilly and Company·Oct 28, 2026

Eli Lilly and Company announced positive topline results from the TRANSCEND-T2D-2 Phase 3 trial on October 28, 2026. The trial compared retatrutide with Ozempic 2 mg in adults with type 2 diabetes over 80 weeks. Participants taking retatrutide achieved an average A1C reduction of 2.2% versus 1.8% for Ozempic, and lost an average of 44.3 lbs to 47.4 lbs compared to 20.9 lbs for Ozempic.

Source: PR NewswireIndustry HEAIndustry MTCIndustry PHASubject TRI

Press releaseLIILennox International Inc.·Oct 28, 2026

Source: PR NewswireIndustry UTIIndustry CSTIndustry HOUIndustry OILIndustry HVASubject ERN

Press releaseSWSmurfit WestRock Plc·Oct 28, 2026

Smurfit WestRock Plc reported financial results for the third quarter ended September 30, 2026, announcing net sales of $8,161 million and net income of $219 million. The company reported adjusted EBITDA of $1,205 million and approved a quarterly dividend of $0.4523 per ordinary share. President and CEO Tony Smurfit noted the resilient performance amidst cost inflation and lower converting volumes.

Source: SEC EDGAR

Press releaseAONAon plc Class A·Oct 28, 2026

Aon plc reported third-quarter 2026 financial results, announcing total revenue of $4.1 billion, representing a 3% increase compared to the prior-year period. Organic revenue grew by 6%, driven by broad-based strength across solution lines including Commercial Risk and Reinsurance. Diluted earnings per share were $2.23, while adjusted diluted earnings per share reached $3.36.

Source: SEC EDGAR